KREITZER ANATOL (Chief Discovery Officer) sold 17.7% of their position (45.42K shares) of MAPLIGHT THERAPEUTICS, INC. on the open market
Open‑market sale worth $1.35M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 4/29/2026ACC: 0002021238-26-000008
Officer· Chief Discovery Officer
Since Feb 2026
-45.42K
Net shares
Net seller
$1.35M
Total sold
3
Open market trades
0B · 3S
3
Total transactions
45.42K disposed
Non-Derivative Transactions3
Voting Common Stock
Direct
Shares
−8.35K
Price / share
$28.96
Trade value
$241.70K
% of position
3.3%
4/27/2026
256.61K→248.27K
Voting Common Stock
Direct
Shares
−29.25K
Price / share
$29.63
Trade value
$866.83K
% of position
11.8%
4/27/2026
248.27K→219.01K
Voting Common Stock
Direct
Shares
−7.82K
Price / share
$30.50
Trade value
$238.54K
% of position
3.6%
4/27/2026
219.01K→211.19K
Total
Net shares
−45.42K
Net value
-$1.35M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Voting Common Stock Direct | 4/27/2026 | S · Sale | −8.35K | $28.96 | $241.70K | 3.3% | 256.61K | 248.27K |
| Voting Common Stock Direct | 4/27/2026 | S · Sale | −29.25K | $29.63 | $866.83K | 11.8% | 248.27K | 219.01K |
| Voting Common Stock Direct | 4/27/2026 | S · Sale | −7.82K | $30.50 | $238.54K | 3.6% | 219.01K | 211.19K |
| Total | −45.42K | -$1.35M | ||||||
Derivative Transactions0
No derivative transactions reported